Targeting Tumor Stroma
Fibroblast Matrix Disruption
Our project focuses on disrupting cancer-associated fibroblasts’ ability to maintain their matrix, potentially reducing pancreatic cancer progression and enhancing treatment efficacy against this aggressive disease.
Innovative Cancer Strategies
We aim to unlock new therapeutic strategies by targeting fibronectin and the extracellular matrix, addressing the critical role of cancer-associated fibroblasts in pancreatic adenocarcinoma progression and drug resistance.
Pancreatic Cancer Research
Our research investigates the dense stroma’s impact on tumor behavior, focusing on the role of fibronectin produced by cancer-associated fibroblasts in promoting tumor initiation, progression, and immune evasion.
Targeting Pancreatic Cancer
-
Innovative Strategies to Target Cancer-Associated Fibroblasts in Pancreatic Cancer
The Role of Cancer-Associated Fibroblasts Pancreatic adenocarcinoma (PDAC) stands out as one of the most aggressive forms of cancer, characterized…
-
Unlocking New Strategies to Combat Pancreatic Cancer
Understanding Pancreatic Cancer and Its Challenges Pancreatic adenocarcinoma (PDAC) is one of the most aggressive types of cancer, characterized by…
